Last reviewed · How we verify
NCT05551442
A Controlled Study of Improved Javelin Side Recumbent Position and Conventional Postural Placement
trial testing To explore the comparative study of different positioning methods in robot assisted laparoscopic pyeloplasty. in Nurse-Patient Relations in 60 participants. Completed in 7 September 2022.
9 January 2022
Quick facts
| Lead sponsor | Guiyang Maternal and Child Health Care Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 12 December 2021 |
| Primary completion | 9 January 2022 |
| Estimated completion | 7 September 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- To explore the comparative study of different positioning methods in robot assisted laparoscopic pyeloplasty.
- To discuss the comparative study of different position placement methods of renal pelvis ureteroplasty on the Da Vinci robotic Xi platform
Conditions studied
- Nurse-Patient Relations — all drugs for Nurse-Patient Relations →
Sponsor
Guiyang Maternal and Child Health Care Hospital
Who can join
Adults 2 Months to 5, any sex, with Nurse-Patient Relations. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Da Vinci surgical robot Xi system assisted laparoscopic pyeloureteroplasty uses the improved javelin side lying position, which can alleviate the unsafe factors of falling from the bed caused by the conventional posture, shorten the time of placing the posture5, prevent the possible pressure injuries and intraoperative complications caused by the conventional posture surgery, and the operation is more simple and convenient. The mechanical arm of the Da Vinci robot will not have the potential risk factors of crushing the head, face and trunk of the patient during the entire operation process, It is safe and reliable, making the whole process of positioning convenient and time-saving. It can not only improve the connection efficiency of each operation, but also ease the work intensity of nurses and reduce the incidence of robot secondary berths. Operator satisfaction. It is safe and reliable to achieve good results, improve the operation safety, effectively avoid intraoperative and postoperative complications, and ensure the operation safety of patients, which is worth promoting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05551442
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nurse-Patient Relations
Currently open trials in the same condition.
- NCT06332495 — Research Project on the Risk of Discomfort, Pain, Alteration of Skin Condition in Bedpan Use by Patients and Caregivers · recruiting
- NCT06783582 — Effectiveness of Motivational Interviewing in Patients With COPD · NA · recruiting
- NCT06174844 — Assessment of the Humanisation of Care in Hospitals in Andalusia-Spain · recruiting
- NCT06067672 — The Patient's First Point of Contact · recruiting
- NCT05780164 — Improving Access to Lung Cancer Clinical Trials · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05551442 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guiyang Maternal and Child Health Care Hospital
- Last refreshed: 22 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05551442.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing